Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial

<div>ADAS-cog outcome: mean change from baseline in patients with aMCI (ITT-LOCF analysis).<i> Notes</i>. ADAS-cog = Alzheimer’s Disease Assessment Scale-cognitive subscale. Graphs show data at baseline and each assessment point.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial 